Raagbp Pharmaceuticals Private Limited

Raagbp Pharmaceuticals Private Limited - healthcare in Delhi, India. FY 2026 financials & compliance.
CIN U24230DL2019PTC355706 Incorporated 01 October 2019 ROC Delhi HQ Delhi, India
Active Private Limited Company healthcare DPIIT Startup MSME · Micro
Data last updated
Revenue · FY 2025
₹10.5 Lakh
▲ 29% YoY
Net loss · FY 2025
₹20.21 Lakh
Net margin -192.4%
EBITDA · FY 2025
₹47,234
EBITDA margin 4.5%
Authorised capital
₹4.5 Cr
Registered with MCA
Paid-up capital
₹92.14 Lakh
Issued & subscribed
Open charges
₹22.3 Cr
Satisfied ₹8.03 Cr
Company age
7 yrs
Est. 2019
Directors on board
2
As per MCA filings

About Raagbp Pharmaceuticals Private Limited

Data last updated:

Raagbp Pharmaceuticals Private Limited is a private limited company based in Delhi, India, recognised as a startup by DPIIT. It operates in the preventive healthcare segment of the healthcare sector. It was incorporated on 01 October 2019 and has been in existence for over 7 years.

The company is registered with the Registrar of Companies (ROC), Delhi, under CIN U24230DL2019PTC355706. Its GSTIN is 02AAJCR8378L1ZS (Himachal Pradesh).

The company has an authorised share capital of ₹4.5 Cr and a paid-up capital of ₹92.14 Lakh. It is led by directors Rama Kant Goyal and Avinash Goyal.

Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at H No.2027 – B Pvt – 2027/156 Plot No Old – 124 – 125 Kh.No 243 Ground Floor Ganeshpura – B, Delhi, India – 110035.

As per the financials filed for FY 2025, the company reported a revenue of ₹10.5 Lakh, a growth of 29% compared to the previous year. For the same year it recorded a net loss of ₹20.21 Lakh (net margin -192.4%) and EBITDA of ₹47,234 (EBITDA margin 4.5%). Revenue has grown at a compounded annual rate (CAGR) of 14% over three years.

As per MCA filings, the company has open charges of ₹22.3 Cr and satisfied charges of ₹8.03 Cr on record. The company has 1 deal on record (1 funding round), with disclosed funding of ₹1.01 Cr; the latest was in December 2022.

Raagbp Pharmaceuticals Private Limited is registered as a micro enterprise under the Udyam registration framework (Reg. No. UDYAM-DL-06-0001968).

Company details

CIN U24230DL2019PTC355706
Registration Number 355706
Incorporation Date 01 October 2019
ROC Delhi
Listing Status Unlisted
Company Status Active
Date of Last AGM 30 September 2025
Date of Balance Sheet 31 March 2025
DPIIT Recognition Recognised Startup
MSME Classification Micro
Udyam Registration UDYAM-DL-06-0001968
Key People
Rama Kant Goyal Director Avinash Goyal Director

Recognitions & Rankings of Raagbp Pharmaceuticals

DPIIT recognised startup Government of India
Startup India
MSME (Udyam registered) Ministry of MSME
Category
Micro (2024-25)
Udyam number
UDYAM-DL-06-0001968

Contact details

Raagbp Pharmaceuticals Private Limited's registered office is in Delhi, Delhi. Its e-mail address and telephone number are in the company report.

  • Email
  • Telephone
  • Registered Address
    H No.2027 – B Pvt – 2027/156 Plot No Old – 124 – 125 Kh.No 243 Ground Floor Ganeshpura – B, Delhi, India – 110035
  • Industry
    Healthcare, Preventive Health Services

To see the full contact details of Raagbp Pharmaceuticals Private Limited, buy the company report.

Comprehensive company report
Raagbp Pharmaceuticals Private Limited - one report that includes everything
  • Company details, directors and signatories
  • Historical financials and ratios
  • Shareholding pattern and group structure
  • Charges with holder and property details
  • Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included

Business activity

The main business activity of Raagbp Pharmaceuticals is manufacturing. In detail, this covers chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.

Main activity group codeMain activityBusiness activity codeBusiness activityShare of turnover
CManufacturingC6Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products

To see the full business activity and turnover split of Raagbp Pharmaceuticals Private Limited, buy the company report.

Financials of Raagbp Pharmaceuticals Private Limited

FY 2025 filings available

Raagbp Pharmaceuticals Private Limited reported revenue of ₹10.5 Lakh (up 29% YoY) for FY 2025.

Revenue · FY 2025
₹10.5 Lakh ▲ 29%
Net loss · FY 2025
₹20.21 Lakh margin -192.4%
EBITDA · FY 2025
₹47,234 margin 4.5%

Compounded Annual Growth Rate (CAGR)

Revenue CAGR growth
1 year
▲ 29%
3 years · compounded
▲ 14%
EBITDA CAGR growth
1 year
▼ 90%
3 years · compounded
▼ 53%
5 years · compounded
▲ 45%

Revenue has grown at a compounded annual rate (CAGR) of 14% over three years, including 29% growth in the latest year. EBITDA fell 90% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.

Financial Statement Summary

MetricsFY 2024-25FY 2023-24FY 2022-23FY 2021-22FY 2020-21
Profit and Loss Statement
Revenue from Operations
Other Income
Total Revenue
Cost of Materials Consumed
Employee Benefit Expense
Finance Costs
Depreciation and Amortisation
Other Expenses
Total Expenses
EBITDA₹47,234
Profit Before Tax
Tax Expense
Net Profit (PAT)-₹20.21 Lakh
Balance Sheet
Share Capital
Reserves and Surplus
Net Worth (Total Equity)
Long-term Borrowings
Short-term Borrowings
Trade Payables
Total Liabilities
Fixed Assets
Investments
Inventories
Trade Receivables
Cash and Bank Balance
Total Assets

Financial Ratios

MetricsFY 2024-25FY 2023-24FY 2022-23FY 2021-22FY 2020-21
Profitability
EBITDA Margin4.5%
Net Profit Margin-192.4%
Return on Equity (ROE)
Return on Capital Employed (ROCE)
Return on Assets (ROA)
Liquidity and Debt
Current Ratio
Quick Ratio
Debt-to-Equity Ratio
Interest Coverage Ratio
Efficiency and Growth
Asset Turnover
Receivable Days
Payable Days
Inventory Days
Revenue Growth
Net Profit Growth

To see the full financial statements and ratios of Raagbp Pharmaceuticals Private Limited, buy the company report.

Board of directors of Raagbp Pharmaceuticals Private Limited

Raagbp Pharmaceuticals has 2 directors on record. No former directors are listed.

Current Directors
NameDesignationAppointment DateTenureStatus
Rama Kant GoyalDirector01 Oct 20197 Years 0 MonthsCurrent
Avinash GoyalDirector01 Oct 20197 Years 0 MonthsCurrent
View all directors

Auditor

Raagbp Pharmaceuticals Private Limited is audited by L A W B A R & ASSOCIATES for the financial year 2022.

Auditor firmFinancial yearFirm registration number
L A W B A R & ASSOCIATESFY 2022030720N

Shareholding

The shareholding of Raagbp Pharmaceuticals Private Limited is on record for 2 financial years, the latest being FY 2021, split between promoters, domestic institutions, public shareholders and others.

Shareholder categoryFY 2021FY 2020
Promoters
Domestic institutional investors (DII)
Public
Others

To see the full shareholding pattern of Raagbp Pharmaceuticals Private Limited, buy the company report.

Charges & borrowings

Open charges
₹22.3 Cr
Satisfied charges
₹8.03 Cr
Breakdown by lending institutions
Others₹22.30 Cr
Latest charge details
DateCharge IDLenderAmountStatusModified or satisfied on
24 Dec 2025101234416Others₹16 CrOpen
24 Dec 2025101234478Others₹6.3 CrOpen
16 Jul 2024100977060Axis Bank Limited₹4.18 CrSatisfied
17 Nov 2022100684198Canara Bank₹3.85 CrSatisfied

To see the full charge records of Raagbp Pharmaceuticals Private Limited, buy the company report.

Total charge records: 4 View all charges

Deals & funding

Raagbp Pharmaceuticals Private Limited has 1 deal on record (1 funding round), with disclosed funding of ₹1.01 Cr; the latest was in December 2022.

Total deals
1
Funding round
1
Disclosed funding
₹1.01 Cr

Deals on record (1 of 1)

WhenDealAmountParties
Dec 2022Funding round₹1.01 CrInvestors: 2 individuals

Deal records are compiled from filings and public sources; amounts are shown only where the source reported them.

MSME payment delays

No delayed payments to MSME suppliers are on our record for Raagbp Pharmaceuticals Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.

GST

Raagbp Pharmaceuticals has 1 GST registration: 1 active.

Total GSTINs
1
Active
1
GSTINStateStatusRegistered on
02AAJCR8378L1ZSHimachal PradeshActive09 Nov 2021

To see the full GST registrations and return filing status of Raagbp Pharmaceuticals Private Limited, buy the company report.

Recent activity

Raagbp Pharmaceuticals Private Limited has 2 board changes on record since 2019: 2 appointments. The latest: Avinash Goyal was appointed as Director on 01 Oct 2019.

Charges
A charge with Others amounted to Rs. 16.00 Cr with Charge ID 101234416 was registered on 24 Dec 2025.
Charges
A charge with Others amounted to Rs. 6.30 Cr with Charge ID 101234478 was registered on 24 Dec 2025.
Charges
A charge registered on 16 Jul 2024 via Charge ID 100977060 with Axis Bank Limited was fully satisfied on 15 Nov 2025.
AGM
Raagbp Pharmaceuticals Private Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records.
Filing
Raagbp Pharmaceuticals Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Delhi Ii.
Charges
A charge with Axis Bank Limited amounted to Rs. 4.18 Cr with Charge ID 100977060 was registered on 16 Jul 2024.
Charges
A charge registered on 17 Nov 2022 via Charge ID 100684198 with Canara Bank was fully satisfied on 30 Nov 2023.
Charges
A charge with Canara Bank amounted to Rs. 3.85 Cr with Charge ID 100684198 was registered on 17 Nov 2022.
Appointed
Avinash Goyal was appointed as Director.
Appointed
Rama Kant Goyal was appointed as Director.
Incorporation
01 Oct 2019
Raagbp Pharmaceuticals Private Limited was registered on 01 Oct 2019 with Roc Delhi Ii & aged 7 years 1 month as per MCA records.

Frequently asked questions

Raagbp Pharmaceuticals is an active private limited company based in Delhi, India. The company works in preventive health services, within the healthcare industry. It was incorporated on 01 October 2019 (7+ years old) and is registered under CIN U24230DL2019PTC355706.

Raagbp Pharmaceuticals has 2 current directors:

The latest financial statements of Raagbp Pharmaceuticals on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from FY 2020 are in the company report.

The GSTIN of Raagbp Pharmaceuticals is 02AAJCR8378L1ZS, registered in Himachal Pradesh.

The CIN (Corporate Identification Number) of Raagbp Pharmaceuticals is U24230DL2019PTC355706. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.

Raagbp Pharmaceuticals was incorporated on 01 October 2019, making it 7+ years old. It is registered with the Registrar of Companies, Delhi.

Raagbp Pharmaceuticals has 1 deal on record (1 funding round), with disclosed funding of ₹1.01 Cr; the latest was in December 2022.

Avinash Goyal was appointed as Director on 01 Oct 2019. Rama Kant Goyal was appointed as Director on 01 Oct 2019.

Yes, Raagbp Pharmaceuticals is recognised as a startup by the Department for Promotion of Industry and Internal Trade (DPIIT).

Yes, Raagbp Pharmaceuticals is registered as a micro enterprise under Udyam registration (number: UDYAM-DL-06-0001968).